Profil
Peter A. LaCrosse is currently the President & Chief Operating Officer at Precidiag, Inc. He previously worked as the Vice President-US Operations at febit holding GmbH and as the Chief of Staff at Arch Therapeutics, Inc. LaCrosse completed his undergraduate degree at Embry-Riddle Aeronautical University.
Postes actifs de Peter A. LaCrosse
| Sociétés | Poste | Début |
|---|---|---|
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | President | - |
Anciens postes connus de Peter A. LaCrosse
| Sociétés | Poste | Fin |
|---|---|---|
| ARCH THERAPEUTICS, INC. | Responsable des Ressources Humaines | - |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services Designs and develops technologies for DNA analysis | Corporate Officer/Principal | - |
Formation de Peter A. LaCrosse
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Embry-Riddle Aeronautical University
Embry-Riddle Aeronautical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
febit holding GmbH
febit holding GmbH Medical/Nursing ServicesHealth Services Designs and develops technologies for DNA analysis | Health Services |
Arch Therapeutics, Inc.
Arch Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel approach to stop bleeding, control leaking and manage wounds during surgery, trauma & interventional care | Health Technology |
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Technology Services |
















